Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of UGT Genetic Variation on Pharmacokinetics of Empagliflozin

NCT05036421 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT05036421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05036421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of UGT Genetic Variation on Pharmacokinetics of Empagliflozin
Lead sponsor
Ain Shams University
Phase
Phase 3
Overall status
Completed
Start date
February 15, 2022
Completion date
May 20, 2022
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacogenomic, pharmacokinetics